Fund Holdings — Stonepine Capital Management, LLC

Total Portfolio Value:
$126.06M
Total Bought:
$30.21M
Total Sold:
$132.52M
Net Transaction:
-$102.31M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Evolus, Inc.(EOLS)5,333,0042,674,356-2,658,648$56.16M$37.44M29.70%-$18.72M
Adma Biologics Inc9,222,6173,426,882-5,795,735$41.69M$22.62M17.94%-$19.07M
Alimera Sciences Inc3,999,4594,051,072+51,613$17.28M$15.80M12.53%-$1.48M
Lakefront Biotherapeutics NVADR(LKFT)261,870393,634+131,764$10.65M$12.68M10.05%+$2.03M
Revance Therapeutics Inc01,976,342+1,976,342$0$9.72M7.71%+$9.72M
Xoma Corp250,000253,770+3,770$4.63M$6.10M4.84%+$1.48M
TELA Bio, Inc.(TELA)317,782688,200+370,418$2.10M$3.90M3.10%+$1.80M
Nektar Therapeutics(NKTR)03,480,409+3,480,409$0$3.25M2.58%+$3.25M
Milestone Pharmaceuticals Inc.(MIST)01,462,296+1,462,296$0$2.62M2.08%+$2.62M
Scpharmaceuticals Inc0446,776+446,776$0$2.24M1.78%+$2.24M
CalciMedica, Inc.(CALC)0522,602+522,602$0$2.17M1.72%+$2.17M
Anika Therapeutics Inc060,949+60,949$0$1.55M1.23%+$1.55M
Rigel Pharmaceuticals Inc01,040,241+1,040,241$0$1.54M1.22%+$1.54M
Aytu Biopharma Inc472,469472,4690$1.34M$1.44M1.14%+$94.5K
Xeris Biopharma Holdings Inc5,937,000598,086-5,338,914$13.95M$1.32M1.05%-$12.63M
Exagen Inc.(XGN)669,684384,600-285,084$1.33M$611.5K0.49%-$721.2K
Adicet Bio Inc0141,548+141,548$0$332.6K0.26%+$332.6K
Rezolute, Inc.(RZLT)2,768,656121,479-2,647,177$2.75M$309.8K0.25%-$2.44M
Io Biotech Inc1,666,037156,167-1,509,870$3.13M$270.2K0.21%-$2.86M
SCYNEXIS, Inc.(SCYX)1,355,18695,637-1,259,549$3.02M$140.6K0.11%-$2.88M
Amylyx Pharmaceuticals, Inc.(AMLX)2,500,0000-2,500,000$36.80M$0—-$36.80M
Atea Pharmaceuticals, Inc.(AVIR)839,5140-839,514$2.56M$0—-$2.56M
Atyr Pharma Inc482,2580-482,258$680.0K$0—-$680.0K
QuidelOrtho Corporation(QDEL)450,0000-450,000$33.16M$0—-$33.16M
Page 1 of 1
Stonepine Capital Management, LLC — 13F Holdings — Q1 2024 | TickerTrail